EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cachexia Alters Central Nervous System Morphology and Functionality in Cancer Patients

Estefania Simoes iD, Ricardo Uchida, Mariana P Nucci, Fabio L S Duran, Joanna D C C Lima, Leonardo R Gama, Naomi A Costa, Maria C G Otaduy, Fang C Bin, Jose P Otoch, Paulo Alcantara, Alexandre Ramos und 7 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.13742 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Estefania Simoes und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Metabolism Research Group (LIM26-HCFMUSP), Department of Surgery, São Paulo, Brazil. Hauptthemen laut MEDLINE: Cachexia, Neoplasms, Central Nervous System. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cachexia is a clinically challenging multifactorial and multi‐organ syndrome, associated with poor outcome in cancer patients, and characterised by inflammation, wasting and loss of appetite. The syndrome leads to central nervous system (CNS) function dysregulation and to neuroinflammation; nevertheless, the mechanisms involved in human cachexia remain unclear.

Methods

We used in vivo structural and functional magnetic resonance imaging (Cohort 1), as well as postmortem neuropathological analyses (Cohort 2) in cachectic cancer (CC) patients compared to weight stable cancer (WSC) patients. Cohort 1 included treatment‐naïve adults diagnosed with colorectal cancer, further divided into WSC ( n = 12; 6/6 [male/female], 61.3 ± 3.89 years) and CC ( n = 10; 6/4, 63.0 ± 2.74 years). Cohort 2 was composed by human postmortem cases where gastrointestinal carcinoma was the underlying cause of death (WSC n = 6; 3/3, 82.7 ± 3.33 years and CC n = 10; 5/5, 84.2 ± 2.28 years).

Results

Here we demonstrate that the CNS of CC patients presents regional structural differences within the grey matter (GM). Cachectic patients presented an augmented area within the region of the orbitofrontal cortex, olfactory tract and the gyrus rectus (coordinates X , Y , Z = 6, 20,−24; 311 voxels; pFWE = 0.023); increased caudate and putamen volume (−10, 20, −8; 110 voxel; pFWE = 0.005); and reduced GM in superior temporal gyrus and rolandic operculum (56,0,2; 156 voxels; pFWE = 0.010). Disrupted functional connectivity was found in several regions such as the salience network, subcortical and temporal cortical areas of cachectic patients (20 decreased and 5 increased regions connectivity pattern, pFDR < 0.05). Postmortem neuropathological analyses identified abnormal neuronal morphology and density, increased microglia/macrophage burden, astrocyte profile disruption and mTOR pathway related neuroinflammation ( p < 0.05).

Conclusions

Our results indicate that cachexia compromises CNS morphology mostly causing changes in the GM of cachectic patients, leading to alterations in regional volume patterns, functional connectivity, neuronal morphology, neuroglia profile and inducing neuroinflammation, all of which may contribute to the loss of homeostasis control and to deficient information processing, as well as to the metabolic and behavioural derangements commonly observed in human cachexia. This first human mapping of CNS cachexia responses will now pave the way to mechanistically interrogate these pathways in terms of their therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaNeoplasmsCentral Nervous SystemHumansMaleFemaleMiddle AgedAgedMagnetic Resonance ImagingAged, 80 and over

Stichwörter der Autor:innen

central nervous systemgrey matterhuman cachexianeuroimagingneuroinflammationneuropathology

Autor:innen und Institutionen

  • Cancer Metabolism Research Group (LIM26-HCFMUSP), Department of Surgery, São Paulo, Brazil.
  • Institute for Diabetes and Cancer, Helmholtz Munich, and German Center for Diabetes Research DZD, Neuherberg, Germany.
  • Joint Heidelberg-IDC Translational Diabetes Unit, Inner Medicine, Heidelberg University Hospital, Heidelberg, Germany.
  • Mental Health Department, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
  • Department of Radiology, Faculty of Medicine, Laboratory of Magnetic Resonance in Neuroradiology (LIM44- HCFMUSP), São Paulo, Brazil.
  • Neuroimaging Laboratory (LIM21-HCFMUSP), institute Psychiatry, University of São Paulo, São Paulo, Brazil.

ORCID-Profile: Estefania Simoes

Zitieren

APA

Simoes, E., Uchida, R., Nucci, M. P., Duran, F. L. S., Lima, J. D. C. C., Gama, L. R., Costa, N. A., Otaduy, M. C. G., Bin, F. C., Otoch, J. P., Alcantara, P., Ramos, A., Laviano, A., Diaz, M. B., Esiri, M. M., DeLuca, G. C., Herzig, S., Filho, G. B., & Seelaender, M. (2025). Cachexia Alters Central Nervous System Morphology and Functionality in Cancer Patients. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13742

Vancouver

Simoes E, Uchida R, Nucci MP, Duran FLS, Lima JDCC, Gama LR, et al. Cachexia Alters Central Nervous System Morphology and Functionality in Cancer Patients. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13742

BibTeX
@article{Simoes2025,
  author = {Simoes, Estefania and Uchida, Ricardo and Nucci, Mariana P and Duran, Fabio L S and Lima, Joanna D C C and Gama, Leonardo R and Costa, Naomi A and Otaduy, Maria C G and Bin, Fang C and Otoch, Jose P and Alcantara, Paulo and Ramos, Alexandre and Laviano, Alessandro and Diaz, Mauricio Berriel and Esiri, Margaret M and DeLuca, Gabriele C and Herzig, Stephan and Filho, Geraldo Busatto and Seelaender, Marilia},
  title = {Cachexia Alters Central Nervous System Morphology and Functionality in Cancer Patients},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.13742}
}
Kostenlos starten →